Early Stage Venture Rappta Therapeutics Raises Series A of $10568701

About Rappta Therapeutics

Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.

Website: Learn more on Rappta Therapeutics’s website

Crunchbase: Follow on Crunchbase

Series A – Rappta Therapeutics

Amount Raised9000000 EUR
Announced Date2020-10-13
Equity Only FundingYes
Organization LocationHelsinki, Southern Finland, Finland, Europe
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsNovartis Venture Fund, Novo Holdings
Number of Investors3
Number of Partner Investors3

Written by Startup News

Early Stage Venture Priothera Raises Series A of $35438833

Early Stage Venture Casai Raises Series A of $23000000